A novel dual AMPK activator/mTOR inhibitor inhibits thyroid cancer cell growth.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2015-02-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/jc.2014-1777PMID 25710562PMCID PMC4422890
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Switch in signaling control of mTORC1 activity after oncoprotein expression in thyroid cancer cell lines.

  2014cited by this paper
• The multifaceted activities of AMPK in tumor progression—why the “one size fits all” definition does not fit at all?

  2013cited by this paper
• Treatment with metformin is associated with higher remission rate in diabetic patients with thyroid cancer.

  2013cited by this paper
• Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents.

  2012cited by this paper
• mTOR pathway overactivation in BRAF mutated papillary thyroid carcinoma.

  2012cited by this paper
• Targeting Energy Metabolic and Oncogenic Signaling Pathways in Triple-negative Breast Cancer by a Novel Adenosine Monophosphate-activated Protein Kinase (AMPK) Activator*

  2011cited by this paper
• Synergistic Action of a RAF Inhibitor and a Dual PI3K/mTOR Inhibitor in Thyroid Cancer

  2011cited by this paper
• The influence of the BRAF V600E mutation in thyroid cancer cell lines on the anticancer effects of 5-aminoimidazole-4-carboxamide-ribonucleoside.

  2011cited by this paper
• Metformin Treatment for Small Benign Thyroid Nodules in Patients with Insulin Resistance

  2011cited by this paper
• Role of BRAF in Thyroid Oncogenesis

  2011cited by this paper
• Maintaining Energy Balance in Health and Disease: Role of the AMP-Activated Protein Kinase

  2011cited by this paper
• mTOR regulation of autophagy

  2010cited by this paper
• Development of novel adenosine monophosphate-activated protein kinase activators.

  2010cited by this paper
• BRAF mutation‐selective inhibition of thyroid cancer cells by the novel MEK inhibitor RDEA119 and genetic‐potentiated synergism with the mTOR inhibitor temsirolimus

  2010cited by this paper
• Uncoupling of the LKB1-AMPKα Energy Sensor Pathway by Growth Factors and Oncogenic BRAFV600E

  2009cited by this paper
• Dual inhibition of mitogen-activated protein kinase kinase and mammalian target of rapamycin in differentiated and anaplastic thyroid cancer.

  2009cited by this paper
• Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification.

  2008cited by this paper
• Role of autophagy in cancer

  2007cited by this paper
• AICAR induces phosphorylation of AMPK in an ATM-dependent, LKB1-independent manner

  2007cited by this paper
• AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy

  2007cited by this paper
• AMP-activated protein kinase as a drug target.

  2007cited by this paper
• AMPK: a key sensor of fuel and energy status in skeletal muscle.

  2006cited by this paper
• The five-parameter logistic: a characterization and comparison with the four-parameter logistic.

  2005cited by this paper
• AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism.

  2005cited by this paper
• Management of cellular energy by the AMP‐activated protein kinase system

  2003cited by this paper
• Genomic DNA Extraction and PCR Amplification of Exon 15 of the BRAF Gene and Exons 1 and 2 of the NRAS Gene

  2003cited by this paper
• Carcinoma Overexpression and Overactivation of Akt in Thyroid Updated

  2001cited by this paper
• Dimethylbiguanide Inhibits Cell Respiration via an Indirect Effect Targeted on the Respiratory Chain Complex I*

  2000cited by this paper
• Decreased growth rate and tumour formation of human anaplastic thyroid carcinoma cells transfected with a human thyrotropin receptor cDNA in NMRI nude mice treated with propylthiouracil.

  1996cited by this paper
• Description of a human papillary thyroid carcinoma cell line. Morphologic study and expression of tumoral markers

  1994cited by this paper
• Growth regulation of normal thyroids and thyroid tumors in man.

  1990cited by this paper
• Establishment and biological characterization of an in vitro human cytomegalovirus latency model.

  1987cited by this paper
• Formation and growth of multicellular spheroids of human origin

  1983cited by this paper

• Growth inhibition and toxicity assessments of cis-3,4-diaryl-α-methylene-γ-butyrolactams in cultured human renal cancer cells and zebrafish embryos.

  2025cites this paper
• Uncovering the connection between obesity and thyroid cancer: the therapeutic potential of adiponectin receptor agonist in the AdipoR2-ULK axis

  2024cites this paper
• Autophagy modulation in cancer therapy: Challenges coexist with opportunities.

  2024cites this paper
• Spatial transcriptomics in embryonic mouse diaphragm muscle reveals regional gradients and subdomains of developmental gene expression

  2024cites this paper
• FNDC5 and AKR1B10 inhibit the proliferation and metastasis of adrenocortical carcinoma cells by regulating AMPK/mTOR pathway

  2023cites this paper
• Clinical Implications of mTOR Expression in Papillary Thyroid Cancer—A Systematic Review

  2023cites this paper
• Radioiodine-refractory differentiated thyroid cancer: Molecular mechanisms and therapeutic strategies for radioiodine resistance.

  2023cites this paper
• The new insights into autophagy in thyroid cancer progression

  2023cites this paper
• Metabolic reprogramming in cancer: Mechanisms and therapeutics

  2023cites this paper
• Metformin and thyroid carcinoma incidence and prognosis: A systematic review and meta-analysis

  2022cites this paper
• Ouabain Effects on Human Anaplastic Thyroid Carcinoma 8505C Cells

  2022cites this paper
• Calycosin induces autophagy and apoptosis via Sestrin2/AMPK/mTOR in human papillary thyroid cancer cells

  2022cites this paper
• mTOR as a Potential Target for the Treatment of Microbial Infections, Inflammatory Bowel Diseases, and Colorectal Cancer

  2022cites this paper
• THERAPEUTIC USE OF METFORMIN IN THYROID CANCER

  2022cites this paper
• Discovery of natural adenosine monophosphate‑activated protein kinase activators through virtual screening and activity verification studies.

  2021cites this paper
• Review of pharmacological inhibition of thyroid cancer metabolism

  2021cites this paper
• Inhibition of autophagy mitigates cell migration and invasion in thyroid cancer.

  2021cites this paper
• AMPK–mTOR Signaling and Cellular Adaptations in Hypoxia

  2021cites this paper
• MARCH6 promotes Papillary Thyroid Cancer development by destabilizing DHX9

  2021cites this paper
• Advances in autophagy as a target in the treatment of tumours

  2021cites this paper
• Synergistic effect of metformin and vemurufenib (PLX4032) as a molecular targeted therapy in anaplastic thyroid cancer: an in vitro study

  2021cites this paper
• Proteome Analysis of USP7 Substrates Revealed Its Role in Melanoma Through PI3K/Akt/FOXO and AMPK Pathways

  2021cites this paper
• An aqueous extract of Prunella vulgaris L. inhibits the growth of papillary thyroid carcinoma by inducing autophagy in vivo and in vitro

  2021cites this paper
• Dual-target kinase drug design: Current strategies and future directions in cancer therapy.

  2020cites this paper
• BIRC7 promotes epithelial-mesenchymal transition and metastasis in papillary thyroid carcinoma through restraining autophagy.

  2020cites this paper
• mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges

  2020cites this paper
• Phenformin inhibits proliferation, invasion, and angiogenesis of cholangiocarcinoma cells via AMPK-mTOR and HIF-1A pathways

  2020cites this paper
• Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas

  2020cites this paper
• USP7 regulates melanoma progression through PI3K/Akt/FOXO and AMPK Pathways

  2020cites this paper
• Novel role of SF1 in alleviating thyroid-associated ophthalmopathy through the AMPK/mTOR signaling pathway.

  2019cites this paper
• HMGB1-mediated autophagy regulates sodium/iodide symporter protein degradation in thyroid cancer cells

  2019cites this paper
• The role of the antidiabetic drug metformin in the treatment of endocrine tumors.

  2019cites this paper
• Autophagy modulators for the treatment of oral and esophageal squamous cell carcinomas

  2019cites this paper
• Targeting autophagy in thyroid cancers.

  2019cites this paper
• Role of Metformin in the Treatment of Patients with Thyroid Nodules and Insulin Resistance: A Systematic Review and Meta-Analysis

  2019cites this paper
• Rapamycin Supplementation May Ameliorate Erectile Function in Rats With Streptozotocin-Induced Type 1 Diabetes by Inducing Autophagy and Inhibiting Apoptosis, Endothelial Dysfunction, and Corporal Fibrosis.

  2018cites this paper
• Galla Rhois water extract inhibits lung metastasis by inducing AMPK-mediated apoptosis and suppressing metastatic properties of colorectal cancer cells

  2018influential citation
• Therapeutic advances in anaplastic thyroid cancer: a current perspective

  2018cites this paper
• Exendin‐4 enhances radiation response of prostate cancer

  2018cites this paper
• Novel direct AMPK activator suppresses non-small cell lung cancer through inhibition of lipid metabolism

  2017cites this paper
• Design of Small Molecule Autophagy Modulators: A Promising Druggable Strategy.

  2017cites this paper
• The suppressive effects of Britannin (Bri) on human liver cancer through inducing apoptosis and autophagy via AMPK activation regulated by ROS.

  2017cites this paper
• Activation of AMPK by OSU53 protects spinal cord neurons from oxidative stress

  2017cites this paper
• Targeting PP2A activates AMPK signaling to inhibit colorectal cancer cells

  2017cites this paper
• Perspective on the dynamics of cancer

  2017cites this paper
• Pathological processes and therapeutic advances in radioiodide refractory thyroid cancer.

  2017cites this paper
• RCAN1-4 is a thyroid cancer growth and metastasis suppressor.

  2017cites this paper
• Molecular Targets and Angiogenesis in Renal Cell Carcinoma, A Multitarget Approach: Mini Review.

  2017cites this paper
• Emerging strategies for managing differentiated thyroid cancers refractory to radioiodine

  2016cites this paper
• Targeting myeloid-derived suppressor cells using a novel adenosine monophosphate-activated protein kinase (AMPK) activator

  2016cites this paper
• Metformin Elicits Antitumor Effects and Downregulates the Histone Methyltransferase Multiple Myeloma SET Domain (MMSET) in Prostate Cancer Cells

  2016cites this paper
• mTOR in Multiple Sclerosis

  2016cites this paper
• Metformin pretreatment enhanced learning and memory in cerebral forebrain ischaemia: the role of the AMPK/BDNF/P70SK signalling pathway

  2016cites this paper
• Metformin mediated reversal of epithelial to mesenchymal transition is triggered by epigenetic changes in E-cadherin promoter

  2016cites this paper
• No evidence for a decreased risk of thyroid cancer in association with use of metformin or other antidiabetic drugs: a case-control study

  2015cites this paper
• TMP21 modulates cell growth in papillary thyroid cancer cells by inducing autophagy through activation of the AMPK/mTOR pathway.

  2015cites this paper
• PI3K/AKT Pathway and Its Mediators in Thyroid Carcinomas

  2015cites this paper
• A new appraisal of iodine refractory thyroid cancer.

  2015cites this paper